Norovirus gastroenteritis in immunocompromised patients - Wikidata - awgldk - TriplyDB

Norovirus gastroenteritis in immunocompromised patients

Norovirus gastroenteritis in immunocompromised patients

http://www.wikidata.org/entity/Q27694610

about

A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review Interferon-λ: Immune Functions at Barrier Surfaces and Beyond Multiplex polymerase chain reaction tests for detection of pathogens associated with gastroenteritis Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae Advances in norovirus biology PPNDS inhibits murine Norovirus RNA-dependent RNA-polymerase mimicking two RNA stacking bases Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease Norovirus immunology: Of mice and mechanisms Antiviral targets of human noroviruses What is the reservoir of emergent human norovirus strains?Distribution of Human Norovirus in the Coastal Waters of South Korea.Re-emergence of a GII.4 Norovirus Sydney 2012 Variant Equipped with GII.P16 RdRp and Its Predominance over Novel Variants of GII.17 in South Korea in 2016.Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.The state of norovirus vaccines.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Epidemiology of human noroviruses and updates on vaccine development RNA populations in immunocompromised patients as reservoirs for novel norovirus variants Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples Comprehensive review of human sapoviruses.Clinical and epidemiologic characteristics of norovirus GII.4 Sydney during winter 2012-13 in Beijing, China following its global emergence.Advances in laboratory methods for detection and typing of norovirus Full-genomic analysis of a human norovirus recombinant GII.12/13 novel strain isolated from South Korea Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial Diagnostic yields in solid organ transplant recipients admitted with diarrhea Sequence analysis of the capsid gene during a genotype II.4 dominated norovirus season in one university hospital: identification of possible transmission routes Acute gastroenteritis outbreak caused by a GII.6 norovirus Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children.Current Status of Norovirus Infections in Children in Sub-Saharan Africa.Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients.Treatment of norovirus infections: moving antivirals from the bench to the bedside.Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency.Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.Current tools for norovirus drug discovery

P2860

Q26783083-653930A7-741A-41FC-83CC-24B6AE83A3A4 Q26801049-960EF1E5-B699-4115-956A-0AA89B07D591 Q26829787-5B4F71C5-04CE-4AC9-AC1C-3BF801107219 Q27004488-E6B21308-C425-41A5-BF4D-3CFF5098005F Q27016152-19D0029F-C793-447C-A59D-BD60A195011F Q27689592-FE4AC2D1-2563-4CC1-81D4-35736D1E47A9 Q27703748-00EAE1C1-A936-4CEC-8F82-B126F1B47A88 Q28083087-313B4C37-E72A-4B6E-BE46-F49F94A49575 Q30249527-E481D72F-CFE0-4353-8BB3-598331BDBB00 Q30372827-097E0C4C-0904-4690-8D6E-B200A77B71EF Q30393524-4130C254-5A29-4787-A5AF-6E00E4503221 Q30397892-5EE8098B-F230-45C2-A1C9-2475ACA9235E Q33593133-D0DE9800-1AC0-4862-B8DE-2D9F26DFA30F Q33678125-863B1BAB-F52F-4875-9DFB-87B9FEB193A8 Q33703664-0EFB1316-91C9-420B-9093-D8B0B39F6A6B Q33797877-CF473702-A852-4343-9C0C-B5E20F5F8A95 Q34059136-D739FEA1-AA6B-4844-A414-58C739C09BFF Q34385139-ADC40CFA-752F-4F5F-9530-ADAFFB7C7C9D Q34594999-EBB1036A-0EE1-4B02-A6DA-F950A9FB0B8A Q34647466-458DE0FB-4243-47EB-A833-EE30CDE3ED3E Q34826743-BEACDD58-7CF0-4B4E-BFE5-176B4CE8BA25 Q34971219-8CBEB312-BACE-46CF-989D-F18E5A7E7E0C Q34983000-46121C4B-4750-4165-8ECA-4B6F3187B4EC Q35083077-7CF0A60B-754D-43BC-AF8C-FAAF89E146F4 Q35212408-AF3A9A31-FFBB-4D0F-A314-85B0FEEC866D Q35473645-8DC78C1B-DCAB-429F-927D-4C6D5FE20BFF Q35543160-1BF0E75C-4CF3-4910-AA3B-88E2EF1B76E4 Q35567656-D41A3CED-20AB-4FC6-A982-6059D34AF523 Q35615462-7CE6B5B4-2A4A-4167-B68D-131863824926 Q35744232-A32D9E59-07AC-4354-99FD-10D17E859E7C Q35792986-42B0C19C-2FA3-40FE-B1D4-2D82D7D6978B Q35837799-43844769-8A4C-4976-BC40-811B614B792F Q36157186-27895FF5-EB38-4234-BBBA-5CAB147CC738 Q36328925-4C73E4AA-960D-480F-A81C-2291E5B49515 Q36657947-E4BC6BA7-CA18-4947-8376-7E91622ADB4E Q36691408-AF1204B7-480A-422F-B7D6-EC21612094F6 Q36736602-0676DC0A-3C46-4717-BC7D-AC161B7A13D1 Q36841045-E0DECA39-9D77-4934-8F4B-3F66F02CEDAE Q36987600-EB570753-FD8F-484F-9E39-47CA40CAE7A1 Q37062340-82BF9771-4B51-47D1-87F8-E3ECC0185BA9

P2860

Norovirus gastroenteritis in immunocompromised patients

http://www.wikidata.org/entity/Q27694610

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Norovirus gastroenteritis in immunocompromised patients

@ast

Norovirus gastroenteritis in immunocompromised patients

@en

Norovirus gastroenteritis in immunocompromised patients

@nl

type

label

Norovirus gastroenteritis in immunocompromised patients

@ast

Norovirus gastroenteritis in immunocompromised patients

@en

Norovirus gastroenteritis in immunocompromised patients

@nl

prefLabel

Norovirus gastroenteritis in immunocompromised patients

@ast

Norovirus gastroenteritis in immunocompromised patients

@en

Norovirus gastroenteritis in immunocompromised patients

@nl

P1433

Q27694610-AB6C8EFB-DF2C-4B0A-A451-B8EFBBFE2BF5

P1476

Q27694610-7B180F28-9093-42CD-942D-031F4C0384A0

P2093

Q27694610-6B114AEC-B011-4E91-B30D-52963B02EDC6

Q27694610-9AA5E3DD-85DF-496C-9954-37E2A61C4153

P2860

Q27694610-010F19AC-1118-4706-A38F-6D4673647D43

Q27694610-07DECD5D-97EF-4401-9DAA-6799743D1F78

Q27694610-0B8EDECB-9DE2-4D73-ADCF-1F4F64304639

Q27694610-148EB49D-8E83-4EC1-BAE4-198377428CDB

Q27694610-1739AE09-6394-4EDA-88CD-917378E73C40

Q27694610-3A2D13CC-EF06-47D9-A605-798A8CAAD830

Q27694610-3CAE9503-9F00-4058-87CE-4A066225263A

Q27694610-4940FFFE-1703-43F2-B53E-6D7B14705D3F

Q27694610-4F1F6E57-2D22-49DA-8A79-632D04156435

Q27694610-5789F65C-E735-4816-BC6E-B10D968E06D4

P304

Q27694610-FBA3FFB3-793A-454A-9D02-EE1A8D31F621

P31

Q27694610-06412417-5373-473E-896F-D4493199C98F

Q27694610-7149e590-147b-4265-bbc6-85cded8a46b3

P3181

Q27694610-05E043D4-1BA9-4863-97A9-10D975F52460

P356

Q27694610-80635F74-81AC-4CB6-B3F8-0514C29B18AD

P407

Q27694610-02F8AAFF-7ED0-4D7D-B8A7-78B6A6C7C0C3

P433

Q27694610-3C2DC082-80EF-4296-A626-2E6EFA03F6FB

P478

Q27694610-E709BFD7-891D-40B3-B149-0919B4577059

P577

Q27694610-2CE2A15B-45EF-4B45-9571-59A99323B500

P698

Q27694610-07E575F3-F44E-41F9-A606-CF492350C320

P921

Q27694610-28B453E0-C7F6-4FF7-A20A-DAB56FFE8067

Q27694610-CBAEF100-15FF-4D57-A830-5543CF08A4F1

Q27694610-DE9D2359-1555-498A-9588-276998963C7E

P932

Q27694610-6F9ADA13-9103-4A7D-AF81-E94E3A8FE48A

P3181

P356

P1433

The New England Journal of Medicine

P1476

Norovirus gastroenteritis in immunocompromised patients

@en

P2093

Karin Bok

http://www.w3.org/2001/XMLSchema#string

Kim Y. Green

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Mechanisms of GII.4 norovirus persistence in human populations

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.

Norovirus infections in preterm infants: wide variety of clinical courses.

Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution.

Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases.

Chimpanzees as an animal model for human norovirus infection and vaccine development.

Chronic shedders as reservoir for nosocomial transmission of norovirus

Systematic literature review of role of noroviruses in sporadic gastroenteritis

P304

2126-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2060804

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMRA1207742

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23190223

http://www.w3.org/2001/XMLSchema#string

P921

gastroenteritis

P932

4944753

http://www.w3.org/2001/XMLSchema#string